Seviteronel (VT-464) - Durham's Innoc... - Advanced Prostate...

Advanced Prostate Cancer

21,007 members26,181 posts

Seviteronel (VT-464) - Durham's Innocrin Nabs FDA Fast Track OK for Prostate Cancer Drug

JLS1 profile image
JLS1
7 Replies

Does anyone know anything about this drug?

Seviteronel (VT-464) - Durham's Innocrin Nabs FDA Fast Track OK for Prostate Cancer Drug

ncbiotech.org/news/durhams-...

"The FDA has granted a fast track designation for Innocrin’s seviteronel (VT-464) for the treatment of patients with metastatic castrate-resistant prostate cancer (CRPC). Fast tracking is a way the FDA speeds its review of promising new therapies targeting unmet medical needs."

en.wikipedia.org/wiki/Sevit...

Written by
JLS1 profile image
JLS1
To view profiles and participate in discussions please or .
Read more about...
7 Replies
tango65 profile image
tango65

Kind of similar to abiraterone but it does not require to add prednisone. The clinical trials are "completed".

clinicaltrials.gov/ct2/resu...

ncbi.nlm.nih.gov/pubmed/277...

JLS1 profile image
JLS1 in reply to tango65

Thank you!

tango65 profile image
tango65 in reply to JLS1

Best of luck!!

Tall_Allen profile image
Tall_Allen

It hasn't yet announced any Phase 3 trials. It is a long way off.

JLS1 profile image
JLS1 in reply to Tall_Allen

There appear to be quite a few drugs out there that many people who have exhausted SOC treatments desperately need, but aren't aware of! What's maddening and frustrating is to discover that many oncologists aren't willing to go past SOC to help! So the poor patient and his/her stressed out advocate/s are the ones who have to go out there to find these possible treatments on their own - and hope and pray they can get them in time!! Sorry.... I needed to vent.....

Tall_Allen profile image
Tall_Allen in reply to JLS1

It's not that anyone is "not aware of" them - I have a long list of clinical trials. You can easily look at clinicaltrials.gov. The issue is that we don't yet know if any of them have any effect, or if they do, whether they might make the patient so sick that he will die sooner if he takes it. The SOC is very good, and the FDA has been rushing approval. For some drugs , the FDA has even allowed the drugs to be used without proof that they extend life. The FDA has also shown great flexibility in allowing new indications for drugs that have a known history of safety.

If you want to try a new drug before it's approved, it's easy - enroll in a clinical trial. If you want to repurpose an already approved drug, most oncologists I've met are willing as long as it is safe.

JLS1 profile image
JLS1 in reply to Tall_Allen

What I meant is that it's disheartening when your oncologist doesn't at least suggest looking into clinical trials after telling you there's nothing more he can do. Instead, he's just throwing in the towel.

Thank God for this web site and posters like you who have been incredibly helpful while providing valuable and inspiring information!

You may also like...

Repurposed drugs for Prostate Cancer

Article from NIH on repurposing drugs for Prostate Cancer https://www.mdpi.com/2146836 Magnus

FDA just fast-tracked this. Phase IIb is scheduled to be complete in early 2022. Prevents reoccurrence via. immune system T helper cells.

te-cancer-drug-candidate-rv001-is-granted-fast-track-designation-by-the-fda-301180409.html

FDA Grants Fast Track Designation for 177Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer

ce-FDA-Grants-Fast-Track-Designation-for-177Lu-PNT2002-for-the-Treatment-of-Metastatic-Castration-Re

FDA approves darolutamide for non-metastatic castration-resistant prostate cancer

amide-non-metastatic-castration-resistant-prostate-cancer

FDA Approves another PSMA PET scan for Prostate Cancer Imaging

expanding the network....